Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole
Pantoprazole: Pantoprazole 40 mg daily for 28 days
Study summary
The objective of this clinical trial is to compare which of the two drugs best resolves symptoms in patients diagnosed with erosive and non-erosive gastroesophageal reflux disease, adult males and females. The main question is What is the proportion of patients with resolution of the main symptoms of gastroesophageal reflux disease at four weeks of treatment with pantoprazole vs tegoprazan.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* With endoscopic diagnosis of GERD or NERD (endoscopy ≤ 15 days old)
* With positive impedance pHmetry results (pHmetry ≤ 15 days old)
* With recurrent symptoms of heartburn and regurgitation for a previous period ≥ 3 months old
Exclusion Criteria:
* With known hypersensitivity to tegoprazan, pantoprazole, or any of the components of each formulation
* Subjects with concomitant administration of atazanavir, nelfinavir or rilpivirine
* Nephropathic and/or hepatopathic subjects (including non-alcoholic hepatitis)
* Subjects with upper gastrointestinal tract bleeding
* Subjects with gastric and/or duodenal ulcer 2 months prior to screening
* Subjects with a history of esophageal or gastric surgery
Primary outcome measure(s)
Proportion of subjects with resolution of the main symptoms of gastroesophageal reflux disease — From enrollment to the end of treatment at 4 weeks Carlsson-Dent Questionnaire. These tool consists of 7 multiple-choice questions, using a cut-off point ≥ 4 to be considered positive, which qualitatively assesses symptoms associated with GERD and triggering factors such as diet, posture and medications used.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.